Gene Expression of Osteoprotegerin Ligand, Osteoprotegerin, and Receptor Activator of NF-κB in Giant Cell Tumor of Bone
Top Cited Papers
Open Access
- 1 March 2000
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 156 (3) , 761-767
- https://doi.org/10.1016/s0002-9440(10)64942-5
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Calcitonin receptor antibodies in the identification of osteoclastsBone, 1999
- Osteotropic Agents Regulate the Expression of Osteoclast Differentiation Factor and Osteoprotegerin in Osteoblastic Stromal CellsEndocrinology, 1998
- Detection of estrogen receptor alpha, carbonic anhydrase II and tartrate-resistant acid phosphatase mRNAs in putative mononuclear osteoclast precursor cells of neonatal rats by fluorescence in situ hybridizationJournal of Molecular Endocrinology, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Detection of mRNA for carbonic anhydrase II in human osteoclast-like cells by in situ hybridizationJournal of Bone and Mineral Research, 1993
- What's new in the role of cytokines on osteoblast proliferation and differentiation?Pathology - Research and Practice, 1992
- What's New in Osteodast Ontogeny?Pathology - Research and Practice, 1991
- Human giant cell tumors of bone identification and characterization of cell types.Journal of Clinical Investigation, 1987
- An immunohistological study of giant‐cell tumour of bone: Evidence for an osteoclast origin of the giant cellsThe Journal of Pathology, 1985
- The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cellsThe Journal of Pathology, 1985